000 01159 a2200289 4500
005 20250513133424.0
264 0 _c19980212
008 199802s 0 0 eng d
022 _a0095-1137
024 7 _a10.1128/JCM.36.1.198-202.1998
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEspinel-Ingroff, A
245 0 0 _aIn vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.
_h[electronic resource]
260 _bJournal of clinical microbiology
_cJan 1998
300 _a198-202 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntifungal Agents
_xpharmacology
650 0 4 _aFungi
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aTriazoles
_xpharmacology
650 0 4 _aVoriconazole
650 0 4 _aYeasts
_xdrug effects
773 0 _tJournal of clinical microbiology
_gvol. 36
_gno. 1
_gp. 198-202
856 4 0 _uhttps://doi.org/10.1128/JCM.36.1.198-202.1998
_zAvailable from publisher's website
999 _c9401341
_d9401341